Literature DB >> 15372267

Transient MRI abnormalities associated with partial status epilepticus.

Ilker Kavuk, Susanne Koeppen, Markus Agelink, Arnd Dörfler, Volker Limmroth, Hans-Christoph Diener.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15372267     DOI: 10.1007/s00415-004-0506-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology.

Authors:  W T Blume; H O Lüders; E Mizrahi; C Tassinari; W van Emde Boas; J Engel
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

2.  Diffusion-weighted magnetic resonance imaging in nonconvulsive status epilepticus.

Authors:  K Chu; D W Kang; J Y Kim; K H Chang; S K Lee
Journal:  Arch Neurol       Date:  2001-06

3.  [Reversible bilateral cortical MRI changes as sequelae of status epilepticus].

Authors:  S Weidauer; K Krakow; H Lanfermann; F E Zanella
Journal:  Nervenarzt       Date:  2001-12       Impact factor: 1.214

4.  Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage.

Authors:  P F Fabene; P Marzola; A Sbarbati; M Bentivoglio
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

5.  Focal status epilepticus: follow-up by perfusion- and diffusion MRI.

Authors:  M El-Koussy; J Mathis; K O Lövblad; F Stepper; C Kiefer; G Schroth
Journal:  Eur Radiol       Date:  2001-07-07       Impact factor: 5.315

  5 in total
  2 in total

1.  Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses.

Authors:  R Scheid; R Voltz; T Vetter; O Sabri; D Y von Cramon
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

2.  Understanding and Managing the Ictal-Interictal Continuum in Neurocritical Care.

Authors:  Adithya Sivaraju; Emily J Gilmore
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.